FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Beckman Coulter Chemistry Analyzer Cleared

FDA clears a Beckman Coulter 510(k) for its DxC 500 AU Chemistry Analyzer, an automated analyzer intended for use by small-to-medium-sized labs.

latest-news-card-1
Human Drugs

Dismissal Sought in FDA-483 Anonymity Suit

FDA says that a reverse-FOIA lawsuit seeking to shield an unnamed company attorneys identity in connection with a Form FDA-483 should be dismissed.

latest-news-card-1
Human Drugs

3rd Circuit Flunks FDA Again Over Illegal Generics

The 3rd Circuit Court of Appeals agrees with a Pennsylvania federal court that FDA failed to state the offense under the law in charging generic drug ...

latest-news-card-1
Biologics

Stratus Illegally Marketing Biologics: FDA

FDA warns Stratus Biosystems that it is illegally marketing biological products whose manufacturing has significant deviations from CGMP requirements.

latest-news-card-1
Human Drugs

FDA Denies 2 Vanda Tasimelteon Petitions

FDA says the Teva and Apotex generic forms of Vandas Hetlioz do not violate labeling requirements or raise safety concerns due to some different eleme...

latest-news-card-1
Human Drugs

FDA Approves Eyelid Mite Disease Drug

FDA approves a Tarsus Pharmaceuticals NDA for Xdemvy (lotilaner ophthalmic solution) 0.25% for treating Demodex blepharitis, an eyelid disease caused ...

latest-news-card-1
Medical Devices

CDRH Adds Device Sterilization Standards

CDRH announces new standards recognized by the agency to improve medical device sterilization.

latest-news-card-1
Human Drugs

FDA Expanding CURE ID

An FDA podcast reports ways in which the CURE ID app is being expanded beyond infectious diseases.

latest-news-card-1
Federal Register

Guide on Drug DNA Reactive Impurities

Federal Register notice: FDA makes available a final guidance entitled M7(R2) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmac...

latest-news-card-1
Human Drugs

12 Catalent Inspection Observations

FDA releases the form FDA-483 with 12 observations from an inspection at the Bloomington, IN-based Catalent Indiana sterile drug and biologic product ...